Author: Cellectis Inc.

Posted Date:

May 4, 2026

Cellectis to Report First Quarter Financial Results on May 11, 2026

Cellectis Inc.

May 4, 2026
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

Cellectis Inc.

April 27, 2026
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

Cellectis Inc.

April 13, 2026
Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Cellectis Inc.

March 12, 2026